Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Escherichia coli (E. coli) antigens are surface molecules on E. coli bacteria that elicit immune responses. Key antigens include the O antigen (lipopolysaccharide), K antigen (capsular polysaccharide), H antigen (flagellar protein), and fimbrial antigens. These antigens are crucial for bacterial identification, serotyping, virulence, and host-pathogen interactions. They are targets for diagnostic antibodies and vaccine development.
Antibodies bind to antigens, neutralizing the bacteria or marking it for destruction by the immune system. Vaccines stimulate the production of antibodies.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Escherichia coli Antigen (E. coli Antigen).